Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intrinsic Subtypes from PAM50 Gene Expression Assay in a Population-Based Breast Cancer Cohort: Differences by Age, Race, and Tumor Characteristics

13 Feb 2014

Abstract excerpt

BACKGROUND: Data are lacking to describe gene expression-based breast cancer intrinsic subtype patterns for population-based patient groups. METHODS: We studied a diverse cohort of women with breast cancer from the Life After Cancer Epidemiology and Pathways studies. RNA was extracted from 1 mm punches from fixed tumor tissue. Quantitative reverse-transcriptase PCR was conducted for the 50 genes that comprise the...

Topics

Join the communities discussing this publication.

BRCA gene mutations in cancer
Breast Cancer Treatment Studies
Breast Lesions and Carcinomas

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24521995
DOI: 10.1158/1055-9965.epi-13-1023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intrinsic Subtypes from PAM50 Gene Expression Assay in a Population-Based Breast Cancer Cohort: Differences by Age, Race, and Tumor CharacteristicsPMID 24521995Read ↗

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular MarkersSemantic proximity Read ↗

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor ExpressionSemantic proximity Read ↗

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancerSemantic proximity Read ↗

Etiology of gene expression-based subtypes of breast cancer in the Ghana Breast Health Study.Semantic proximity Read ↗

Robust and Interpretable PAM50 Reclassification Exhibits Survival Advantage for Myoepithelial and Immune PhenotypesSemantic proximity Read ↗

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumSemantic proximity Read ↗

Cross-Platform Reproducible Modeling of Breast Cancer Prognosis Using the Core-PAM50 Gene SignatureSemantic proximity Read ↗

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation statusSemantic proximity Read ↗

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.Semantic proximity Read ↗

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.Semantic proximity Read ↗

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsSemantic proximity Read ↗

PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.